
Authors: Selina Moses PhD, Karen Meyer, Susan Daly PhD, Indermeet Kohli PhD , Tasneem F. Mohammad MD, Henry W. Lim MD , Joshua D. Williams PhD
Presented at the American Academy of Dermatology Annual Meeting March 27-29, 2026

Author: Joshua D. Williams, Tatiana Luts, Mark Benn, Thomas C. Shyr
Presented at the American Academy of Dermatology Annual Meeting March 7-11, 2025
The data says it all. ZYRTEC® provides powerful, consistent relief of seasonal allergic rhinitis1—including bothersome ocular and nasal symptoms2,3
Patients receiving ZYRTEC® reported significantly greater improvement in QOL—and significant reductions in impairment at work—vs placebo*†‡

ZYRTEC® provided symptom relief vs placebo in patients with perennial allergic rhinitis (PAR)

Uncover how to use behavioural science to encourage sun safe lifestyles

ZYRTEC® provided relief of seasonal allergic rhinitis symptoms vs placebo1

Supporting smoking & vaping cessation in Australia: Nicotine dependance and recommending appropriate NRT